Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial

A promising new treatment approach for major depressive disorder (MDD) targets the microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected in MDD. This is the first randomized controlled trial to determine whether short-term, high-dose probiotic supplement...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaub, Anna-Chiara, Schneider, Else, Vazquez-Castellanos, Jorge F., Schweinfurth, Nina, Kettelhack, Cedric, Doll, Jessica P. K., Yamanbaeva, Gulnara, Mählmann, Laura, Brand, Serge, Beglinger, Christoph, Borgwardt, Stefan, Raes, Jeroen, Schmidt, André, Lang, Undine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163095/
https://www.ncbi.nlm.nih.gov/pubmed/35654766
http://dx.doi.org/10.1038/s41398-022-01977-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163095/
https://www.ncbi.nlm.nih.gov/pubmed/35654766
http://dx.doi.org/10.1038/s41398-022-01977-z

Ejemplares similares